PF-08065010
/ Pfizer
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 25, 2026
A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults
(clinicaltrials.gov)
- P1 | N=100 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting
Enrollment open
March 19, 2026
C6341001: A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 are Tolerated and Act in the Body of Healthy Adults
(clinicaltrialsregister.eu)
- P1 | N=100 | Not yet recruiting | Sponsor: Pfizer Inc.
New P1 trial • Immunology • Inflammatory Arthritis • Lupus • Rheumatoid Arthritis • Rheumatology • Systemic Lupus Erythematosus
November 20, 2025
A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults
(clinicaltrials.gov)
- P1 | N=100 | Not yet recruiting | Sponsor: Pfizer
New P1 trial
1 to 3
Of
3
Go to page
1